Authors: MAHMOUD HH LEVERGER G PATTE C HARVEY E LASCOMBES F

Citation: Hh. Mahmoud et al., ADVANCES IN THE MANAGEMENT OF MALIGNANCY-ASSOCIATED HYPERURICEMIA, British Journal of Cancer, 77, 1998, pp. 18-20

Authors: PUI CH RELLING MV LASCOMBES F HARRISON PL STRUXIANO A MONDESIR JM RIBEIRO RC SANDLUND JT RIVERA GK EVANS WE MAHMOUD HH

Citation: Ch. Pui et al., URATE OXIDASE IN PREVENTION AND TREATMENT OF HYPERURICEMIA ASSOCIATEDWITH LYMPHOID MALIGNANCIES, Leukemia, 11(11), 1997, pp. 1813-1816

Authors: KESSLER M GRUNFELD J LASCOMBES F NECCIARI J

Citation: M. Kessler et al., PHARMACOKINETICS OF TILUDRONATE IN PATIENTS WITH CHRONIC SEVERE RENAL-FAILURE, Journal of bone and mineral research, 11, 1996, pp. 662-662

Authors: JACOB F DEBRY G LASCOMBES F NECCIARI J

Citation: F. Jacob et al., TILUDRONATE - PHARMACOKINETIC DOSE PROPORTIONALITY AFTER INTRAVENOUS ADMINISTRATION - ABSOLUTE BIOAVAILABILITY IN HEALTHY-VOLUNTEERS, Journal of bone and mineral research, 11, 1996, pp. 663-663

Authors: CHASSARD D LASCOMBES F CREEK R NECCIARI J

Citation: D. Chassard et al., STUDY OF THE PHARMACOKINETIC INTERACTION BETWEEN TILUDRONATE AND THE NONSTEROIDAL ANTIINFLAMMATORY DRUGS - ASPIRIN, DICLOFENAC AND INDOMETHACIN, Journal of bone and mineral research, 11, 1996, pp. 664-664

Authors: ROYERMORROT MJ ZHIRI A JACOB F NECCIARI J LASCOMBES F ROYER RJ

Citation: Mj. Royermorrot et al., INFLUENCE OF FOOD-INTAKE ON THE PHARMACOKINETICS OF A SUSTAINED-RELEASE FORMULATION OF SODIUM VALPROATE, Biopharmaceutics & drug disposition, 14(6), 1993, pp. 511-518